Literature DB >> 32060695

Impact and relevance of alcohol dehydrogenase enantioselectivities on biotechnological applications.

Afifa Ayu Koesoema1, Daron M Standley2, Toshiya Senda3,4, Tomoko Matsuda5.   

Abstract

Alcohol dehydrogenases (ADHs) catalyze the reversible reduction of a carbonyl group to its corresponding alcohol. ADHs are widely employed for organic synthesis due to their lack of harm to the environment, broad substrate acceptance, and high enantioselectivity. This review focuses on the impact and relevance of ADH enantioselectivities on their biotechnological application. Stereoselective ADHs are beneficial to reduce challenging ketones such as ketones owning two bulky substituents or similar-sized substituents to the carbonyl carbon. Meanwhile, in cascade reactions, non-stereoselective ADHs can be utilized for the quantitative oxidation of racemic alcohol to ketone and dynamic kinetic resolution.

Entities:  

Keywords:  Alcohol dehydrogenase; Asymmetric reduction; Cascade; Enantioselectivity; Enzyme engineering; Pharmaceutical intermediate

Year:  2020        PMID: 32060695     DOI: 10.1007/s00253-020-10440-2

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  3 in total

1.  Deracemization of 1-phenylethanols in a one-pot process combining Mn-driven oxidation with enzymatic reduction utilizing a compartmentalization technique.

Authors:  Hirofumi Sato; Rei Yamada; Yomi Watanabe; Takaaki Kiryu; Shintaro Kawano; Motohiro Shizuma; Hideya Kawasaki
Journal:  RSC Adv       Date:  2022-04-06       Impact factor: 3.361

2.  Organic-inorganic nanocrystal reductase to promote green asymmetric synthesis.

Authors:  Kotchakorn T Sriwong; Afifa Ayu Koesoema; Tomoko Matsuda
Journal:  RSC Adv       Date:  2020-08-20       Impact factor: 4.036

Review 3.  Redesigning Enzymes for Biocatalysis: Exploiting Structural Understanding for Improved Selectivity.

Authors:  Yaoyu Ding; Gustavo Perez-Ortiz; Jessica Peate; Sarah M Barry
Journal:  Front Mol Biosci       Date:  2022-07-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.